Respiratory syncytial virus infects and abortively replicates in the lungs in spite of preexisting immunity

Journal of Virology

Volumn 81, Issue 17, 2007, Pages 9443-9450

  Boukhvalova, Marina S ^a   Prince, Gregory A ^a   Blanco, Jorge C G ^a  

^a Virion Systems Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PALIVIZUMAB; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHIOLITIS; CONTROLLED STUDY; COTTON RAT; GENE EXPRESSION; GROWTH INHIBITION; IMMUNE DEFICIENCY; IMMUNITY; LUNG INFECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGENY; RAT; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RNA TRANSCRIPTION; VIRUS INFECTIVITY; VIRUS PNEUMONIA; VIRUS REPLICATION;

ANIMALS; CELL LINE; DISEASE MODELS, ANIMAL; DNA, VIRAL; HUMANS; LUNG; PLAQUE ASSAY; POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RNA, MESSENGER; RNA, VIRAL; SIGMODONTINAE; VIRAL LOAD;

ANIMALIA; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; SIGMODON;

EID: 34548145070     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00102-07     Document Type: Article

References (44)

1. Alexandersen, S., S. Larsen, A. Cohn, A. Uttenthal, R. E. Race, B. Aasted, M. Hansen, and M. E. Bloom. 1989. Passive transfer of antiviral antibodies restricts replication of Aleutian mink disease parvovirus in vivo. J. Virol. 63:9-17.
2. Arnold, R., B. Konig, H. Galatti, H. Werchau, and W. Konig. 1995. Cytokine (IL-8, IL-6, TNF-α) and soluble TNF receptor-I release from human peripheral blood mononuclear cells after respiratory syncytial virus infection. Immunology 85:364-372.
3. Bermingham, A., and P. L. Collins. 1999. The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription. Proc. Natl. Acad. Sci. USA 96:11259-11264.
4. Blanco, J. C., L. Pletneva, M. Boukhvalova, J. Y. Richardson, K. A. Harris, and G. A. Prince. 2004. The cotton rat: an underutilized animal model for human infectious diseases can now be exploited using specific reagents to cytokines, chemokines, and interferons. J. Interferon Cytokine Res. 24:21-28.
5. Brake, D. A. 2003. Parasites and immune responses: memory illusion? DNA Cell Biol. 22:405-419.
6. Cannon, M. J., P. J. Openshaw, and B. A. Askonas. 1988. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J. Exp. Med. 168:1163-1168.
7. Cattaneo, R., G. Rebmann, K. Baczko, V. ter Meulen, and M. A. Billeter. 1987. Altered ratios of measles virus transcripts in diseased human brains. Virology 160:523-526.
8. Collins, P. L., and G. W. Wertz. 1983. cDNA cloning and transcriptional mapping of nine polyadenylylated RNAs encoded by the genome of human respiratory syncytial virus. Proc. Natl. Acad. Sci. USA 80:3208-3212.
9. de Graaff, P. M., E. C. de Jong, T. M. van Capel, M. E. van Dijk, P. J. Roholl, J. Boes, W. Luytjes, J. L. Kimpen, and G. M. van Bleek. 2005. Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells. J. Immunol. 175:5904-5911.
10. Falsey, A. R., M. A. Formica, J. J. Treanor, and E. E. Walsh. 2003. Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding. J. Clin. Microbiol. 41:4160-4165.
11. Falsey, A. R., M. A. Formica, and E. E. Walsh. 2002. Diagnosis of respiratory syncytial virus infection: comparison of reverse transcription-PCR to viral culture and serology in adults with respiratory illness. J. Clin. Microbiol. 40:817-820.
12. Franke-Ullmann, G., C. Pfortner, P. Walter, C. Steinmuller, M. L. Lohmann-Matthes, L. Kobzik, and J. Freihorst. 1995. Alteration of pulmonary macrophage function by respiratory syncytial virus infection in vitro. J. Immunol. 154:268-280.
13. Glezen, W. P., L. H. Taber, A. L. Frank, and J. A. Kasel. 1986. Risk of primary infection and reinfection with respiratory syncytial virus. Am. J. Dis. Child. 140:543-546.
14. Graham, B. S., L. A. Bunton, J. Rowland, P. F. Wright, and D. T. Karzon. 1991. Respiratory syncytial virus infection in anti-μ-treated mice. J. Virol. 65:4936-4942.
15. Graham, B. S., L. A. Bunton, P. F. Wright, and D. T. Karzon. 1991. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J. Clin. Investig. 88:1026-1033.
16. Gupta, C. K., J. Leszczynski, R. K. Gupta, and G. R. Siber. 1996. Stabilization of respiratory syncytial virus (RSV) against thermal inactivation and freeze-thaw cycles for development and control of RSV vaccines and immune globulin. Vaccine 14:1417-1420.
17. Han, L. L., J. P. Alexander, and L. J. Anderson. 1999. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J. Infect. Dis. 179:25-30.
18. Hardy, R. W., S. B. Harmon, and G. W. Wertz. 1999. Diverse gene junctions of respiratory syncytial virus modulate the efficiency of transcription termination and respond differently to M2-mediated antitermination. J. Virol. 73:170-176.
19. Hornung, V., M. Guenthner-Biller, C. Bourquin, A. Ablasser, M. Schlee, S. Uematsu, A. Noronha, M. Manoharan, S. Akira, A. de Fougerolles, S. Endres, and G. Hartmann. 2005. Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 11:263-270.
20. Hu, A., M. Colella, J. S. Tam, R. Rappaport, and S. M. Cheng. 2003. Simultaneous detection, subgrouping, and quantitation of respiratory syncytial virus A and B by real-time PCR. J. Clin. Microbiol. 41:149-154.
21. Huang, Y. T., and G. W. Wertz. 1982. The genome of respiratory syncytial virus is a negative-stranded RNA that codes for at least seven mRNA species. J. Virol. 43:150-157.
22. Klasse, P. J., and Q. J. Sattentau. 2002. Occupancy and mechanism in antibody-mediated neutralization of animal viruses. J. Gen. Virol. 83:2091-2108.
23. Kolakofsky, D., and A. Bruschi. 1975. Antigcnomes in Sendai virions and Sendai virus-infected cells. Virology 66:185-191.
24. Kolakofsky, D., P. F. Spahr, and H. Koprowski. 1974. Comparison of 6-94 virus and Sendai virus RNA by RNA-RNA hybridization. J. Virol. 13:935-936.
25. Mandel, B. 1967. The interaction of neutralized poliovirus with HeLa cells. I. Adsorption. Virology 31:238-247.
26. Masopust, D., J. Jiang, H. Shen, and L. Lefrancois. 2001. Direct analysis of the dynamics of the intestinal mucosa CDS T cell response to systemic virus infection. J. Immunol. 166:2348-2356.
27. + T cells. Eur. J. Immunol. 23:3306-3311.
28. Neilson, K. A., and E. J. Yunis. 1990. Demonstration of respiratory syncytial virus in an autopsy series. Pediatr. Pathol. 10:491-502.
29. Perkins, S. M., D. L. Webb, S. A. Torrance, C. El Saleeby, L. M. Harrison, J. A. Aitken, A. Patel, and J. P. DeVincenzo. 2005. Comparison of a real-time reverse transcriptase PCR assay and a culture technique for quantitative assessment of viral load in children naturally infected with respiratory syncytial virus. J. Clin. Microbiol. 43:2356-2362.
30. Prince, G. A., V. G. Hemming, R. L. Horswood, P. A. Baron, and R. M. Chanock. 1987. Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton rats. J. Virol. 61:1851-1854.
31. Prince, G. A., V. G. Hemming, R. L. Horswood, and R. M. Chanock. 1985. Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat. Virus Res. 3:193-206.
32. Prince, G. A., A. B. Jenson, V. G. Hemming, B. R. Murphy, E. E. Walsh, R. L. Horswood, and R. M. Chanock. 1986. Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactivated virus. J. Virol. 57:721-728.
33. Prince, G. A., A. B. Jenson, R. L. Horswood, E. Camargo, and R. M. Chanock. 1978. The pathogenesis of respiratory syncytial virus infection in cotton rats. Am. J. Pathol. 93:771-791.
34. Robinson, W. S. 1970. Self-annealing of subgroup 2 myxovirus RNAs. Nature 225:944-945.
35. Schauer, U., S. Hoffjan, J. Bittscheidt, A. Kochling, S. Hemmis, S. Bongartz, and V. Stephan. 2002. RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life. Eur. Respir. J. 20:1277-1283.
36. Schröder, M., and A. G. Bowie. 2005. TLR3 in antiviral immunity: key player or bystander? Trends Immunol. 26:462-468.
37. Schwarze, J., D. R. O'Donnell, A. Rohwedder, and P. J. Openshaw. 2004. Latency and persistence of respiratory syncytial virus despite T cell immunity. Am. J. Respir. Crit. Care Med. 169:801-805.
38. Shay, D. K., R. C. Holman, G. E. Roosevelt, M. J. Clarke, and L. J. Anderson. 2001. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among U.S. children, 1979-1997. J. Infect. Dis. 183:16-22.
39. Sigurs, N., R. Bjarnason, F. Sigurbergsson, and B. Kjellman. 2000. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am. J. Respir. Crit. Care Med. 161:1501-1507.
40. Sioud, M. 2005. Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence dependent and requires endosomal localization. J. Mol. Biol. 348:1079-1090.
41. Stein, R. T., D. Sherrill, W. J. Morgan, C. J. Holberg, M. Halonen, L. M. Taussig, A. L. Wright, and F. D. Martinez. 1999. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 354:541-545.
42. Taylor, G., E. J. Stott, M. Bew, B. F. Fernie, P. J. Cote, A. P. Collins, M. Hughes, and J. Jebbett. 1984. Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology 52:137-142.
43. Thompson, W. W., D. K. Shay, E. Weintraub, L. Brammer, N. Cox, L. J. Anderson, and K. Fukuda. 2003. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289:179-186.
44. Wendt, C. H., and M. I. Hertz. 1995. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host. Semin. Respir. Infect. 10:224-231.